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Introduction: Delusional parasitosis is a rare, monosymptomatic psychosis involving a delusion of being infested
with parasites. It is commonly observed among female patients over the age of 50. It is classified as a ‘delusional
disorder’ according to the 10th revision of the International Classification of Diseases and as a ‘delusional disorder -
somatic type’ according to the Diagnostic and Statistical Manual, Fourth Edition. Delusional parasitosis was reported
to be associated with physical disorders such as hypoparathyroidism, Huntington’s chorea and Alzheimer’s disease,
among others. Other than vitamin deficiencies however, a causal relationship has not to date been identified. We
present this case due to the rarity of Turkish patients with this condition, its duration of follow-up, and its temporal
pattern of symptoms paralleling thyroid function tests.
Case presentation: Our patient was a 70-year-old white Anatolian Turkish woman with primary school education
who had been living alone for the past five years. She presented to our psychiatry department complaining of
‘feeling large worms moving in her body’. The complaints started after she was diagnosed with hyperthyroidism,
increased when she did not use her thyroid medications and remitted when she was compliant with treatment.
She was treated with pimozide 2mg/day for 20 months and followed-up without any antipsychotic treatment for
an additional nine months. At her last examination, she was euthyroid, not receiving antipsychotics and was not
having any delusions.
Conclusion: Although endocrine disorders, including hyperthyroidism, are listed among the etiological factors
contributing to secondary delusional parasitosis, as far as we are aware this is the first case demonstrating a
temporal pattern of thyroid hyperfunction and delusions through a protracted period of follow-up. It may be that
the treatment of delusional parasitosis depends on clarifying the etiology and that atypical antipsychotics may help
in the management of primary delusional parasitosis. Further studies on the relationship between thyroid
hormones and dopaminergic neurotransmission may be warranted.Introduction
Delusional parasitosis (DP) is a monosymptomatic psych-
osis involving a delusion of being infested with parasites
[1]. Patients with DP believe that insects, worms or other
small pests live in their bodies and feed on them [2]. Vis-
ual or tactile hallucinations consistent with thought con-
tent can accompany the delusions. DP is typically
observed in women over the age of 50 although isolated
cases among men have been reported [1-3]. It can be clas-
sified as primary or secondary according to etiology.* Correspondence: eylemozten@yahoo.com
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reproduction in any medium, provided the orPrimary DP is a psychiatric disorder whereas secondary
DP is currently thought of as a symptom rather than a dis-
order. In the latter case, the delusion is secondary to an-
other psychopathology or a medical illness [4,5].
Secondary DP has been associated with diseases and
malignancies of the hematopoietic, pulmonary, cardiac,
renal, gastrointestinal and endocrine systems, infections
of the central nervous system, and nutritional deficien-
cies including vitamin B12, folate and pellagra [1-5].
However, the causal role of the underlying disorder has
rarely been elucidated [1-5].
Although thought to be rare, the true prevalence of
DP may be underestimated because patients do not be-
lieve the psychiatric origin of their complaints and are
reluctant to apply for psychiatric treatment. Most casestd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
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from Asia. Although the number of reported cases
increases steadily, it remains a rare phenomenon. Here,
we report the treatment of a patent with DP thought to
be secondary to hyperthyroidism. This case was deemed
worthy of presentation due to the scarcity of cases from
Turkey, its duration of follow-up, and its temporal pat-
tern of symptoms paralleling thyroid function tests.
Case presentation
Our patient was a 70-year-old white Anatolian Turkish
woman with primary school education who had been liv-
ing alone for the past five years. She presented to our
Psychiatry Department complaining of ‘feeling large
worms moving in her body’. The complaint had been
present for the past six months and started after she pre-
sented to an internist with complaints of weight loss, bilat-
eral fine tremor of the upper extremities, shaking,
sweating, palpitations and intolerance to heat. After the
evaluation, she was hospitalized for a diagnostic work-up
in our Endocrinology Department with a preliminary diag-
nosis of hyperthyroidism. Restlessness, increased speech
and the feeling of ‘large worms migrating through her
body’ were observed on the second day of hospitalization.
After psychiatric consultation, our patient was diag-
nosed with a psychotic disorder due to a general medical
condition (hyperthyroidism). She was started on 2mg/
day of haloperidol. This treatment was chosen because
of the preliminary nature of the diagnosis and because
our patient may have had delirium. Thyroid ultrasonog-
raphy revealed five nodules measuring 2mm to 5mm in
the left lobe and a heterogeneous nodule measuring
5mm to 10mm in the right lobe. None of the nodules
displayed microcalcification, solidity or a reduced echo-
genicity pattern. The solitary nodule in the right lobe
displayed an irregular contour. Lymphadenopathy and
invasion of the neighboring structures were not noted.
Scintigraphy revealed that all of the nodules were hyper-
functioning. She had no history of exposure to ionizing
or environmental toxins, and no personal or family his-
tory of multiple endocrine neoplasia. A fine needle aspir-
ation biopsy ruled out malignancy. The level of antibody
to thyroid stimulating hormone receptor was found to
be 2.5IU/L, thereby confirming Graves' disease.
As a result of the surgical consultation, medical follow-up
was advised. On the third day, propylthiouracil 150mg/day
and propranolol 30mg/day were started and the doses were
maintained at 100mg/day and 40mg/day, respectively, after
the first week. Restlessness, increased speech and DP remit-
ted on the 10th day of treatment and haloperidol was
stopped. She was discharged on the 20th day with a pre-
scription of levothyroxine sodium 100μg/day (weight, 59kg;
dose, 1.7μg/kg/day). A fortnight after discharge, she started
to feel the worms. After presenting to the Departments ofDermatology, Microbiology and Infectious Diseases, Endo-
crinology, and Neurology, she was referred to the Depart-
ment of Psychiatry and hospitalized. Her past medical and
psychiatric histories were negative for pathology and her
family history did not reveal evidence of psychopathology.
She was teetotal and she was receiving no drugs or supple-
ments at the time of evaluation other than levothyroxine
sodium. She had no history of drug use or abuse and an in-
patient follow-up lasting a month did not reveal any signs
or symptoms of withdrawal.
At the baseline examination, she was noted to be co-
operative and have reduced self-grooming. Her speech was
fluent although restricted to the topic of tapeworms. Her
mood and affect were anxious. She was orientated to
people, space and time. Her attention, concentration and
memory were within normal limits. She reported tactile
hallucinations. Her judgment, reality testing and abstract
thinking were impaired and her thought process was perse-
verative and circumferential. Her thought content was posi-
tive for somatic delusions. Motor retardation was observed
while sleep and appetite were normal. Assessment with the
Positive and Negative Syndrome Scale and Mini Mental
State Examination revealed scores of 82 (positive: 19; nega-
tive: 18; general psychopathology: 45) and 28, respectively.
Laboratory examinations including levels of vitamin
B12, folate and ferritin, the Venereal Disease Research
Laboratory test, and a toxicology screen were within nor-
mal limits other than elevated thyroid function tests (our
patient was noncompliant with her levothyroxine treat-
ment, Table 1). After an endocrinology consultation, it was
advised that she be followed without medication for a
month; thereafter, levothyroxine sodium 100μg/day was
restarted. Consultations from the departments of Internal
Medicine, Neurology, Hematology and Oncology ruled
out the presence of an organic disorder. Electroencephal-
ography and cranial magnetic resonance imaging were
normal. Therefore our patient was diagnosed as having
DP, presumably secondary to the hyperthyroidism. A base-
line electrocardiogram (ECG) demonstrated a corrected
QT interval (QTc) duration of 450ms. Previous ECGs
revealed that her QTc duration varied between 440ms and
490ms. Therefore, psychiatric treatment was initiated with
pimozide 2mg/day and later the dose was titrated to 4mg/
day. At the eighth week of treatment her thyroid function
tests returned to normal limits along with a remission of
the delusions. The QTc duration at this time was mea-
sured as 470ms. Our patient was discharged from the hos-
pital and followed-up at the outpatient department. Her
thyroid levels remained normal for a year and she was free
of psychiatric symptoms. Therefore, pimozide was titrated
down to 2mg/day. After 15 months her thyroid hor-
mone levels increased again due to an irregular use of
medication. Consequently, she began to feel the tape-
worms again.
Table 1 The relationship of thyroid function tests with positive and negative syndrome scale scores and psychiatric









Baselined 6.55 2.27 0.007 + 54 (14/9/31)
Month 6 7.95 3.97 0.005 + 82 (19/18/45)
Month 9 3.78 2.19 1.28 - 44 (7/12/25)
Month 15 3.56 1.97 1.32 - 38 (7/8/23)
Month 25 4.58 2.47 0.09 + 68 (15/16/37)
Month 29 3.97 2.07 1.02 - 34 (7/7/20)
a Normal range: 0.2 to 0.5ng/dL; b normal range: 0.7 to 1.8ng/dL; c normal range: 0.3 to 4.5mIU/L; d baseline without levothyroxine - all other levels with 100μg/day
levothyroxine. PANSS: Positive and Negative Syndrome Scale.
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medication was reinstituted. After 20 months of follow-
up the pimozide was stopped and she was followed with-
out antipsychotic treatment for an additional nine
months. At her last examination she was euthyroid, not
receiving antipsychotics and having no delusions.
Discussion
We have described a case of DP thought to be due to
hyperthyroidism and reported its treatment and follow-
up. Many individuals with DP are functional, with a mi-
nority being severely affected. The distress and loss of
functionality reported in our patient shows that she was
severely affected [1]. It has been reported that patients
commonly present for general medical or dermatologic
care, onset is insidious and most patients report symp-
toms lasting at least six months, the diagnosis may take
years to establish, the belief of infestation may be shared,
and that patients do not generally have a history of prior
psychopathology but a history of social isolation [6,7].
These features were also present in our patient.
Hypochondriasis, dementia, mood and anxiety disor-
ders, obsessive compulsive disorder and post-traumatic
stress disorder were ruled out because of the intensity of
conviction, her normal neurological and laboratory evalua-
tions, the lack of previous history for psychiatric disorders
and the absence of traumatic stressors in our patient.
Pimozide was used to treat our patient because, until
recently, it was recommended for use in DP. However, it
is currently not used as a first-line antipsychotic for
patients with DP because of the risk of extrapyramidal
symptoms, longer QTc interval and interactions with
other drugs. Although our patient did not experience
untoward side effects due to interactions with other
agents or extrapyramidal side effects, follow-up ECGs
revealed longer QTc intervals, illustrating the potential
for cardiotoxicity. Several case reports have indicated
the beneficial effects of atypical antipsychotics in pri-
mary DP, such as risperidone, quetiapine, olanzapine and
amisulpride [6-10].The use of haloperidol at 2mg/day at the initial pres-
entation may be an important limitation of our case re-
port. Haloperidol at this dose may not affect delusions
and may lead to increased agitation. However, it was
chosen at this time pending the results of laboratory
tests and to rule out the presence of delirium. The
current consensus is that pharmacological treatment of
delirium is necessary if the patients pose a safety risk to
themselves or others and that both typical and atypical
antipsychotics are effective in the management of delir-
ium, although they lack approval from the US Food and
Drug Administration for this indication [11].
The pathogenesis of DP is currently unknown; proposed
factors include recent awareness of a known disease via
media or another individual, leading to amplification of
somatic sensations; an elevation of extracellular dopamine
within the striatum; social isolation; or stress [1-5,7]. Social
isolation and stress of the diagnosis of hyperthyroidism
may have played a role in our patient but the temporal re-
lationship between thyroid hormone levels and the delu-
sion of parasitosis (Table 1) may also point to a role of
thyroid dysfunction in the development of delusion.
Conclusion
Although endocrine disorders, including hyperthyroidism,
are listed among the etiological factors contributing to
secondary DP, as far as we are aware this is the first case
presentation demonstrating a temporal pattern of thyroid
hyperfunction and delusions through a protracted period
of follow-up. It may be that treatment of DP depends on
clarifying the etiology and that atypical antipsychotics may
help in the management of primary DP. Further studies
on the relationship between thyroid hormones and dopa-
minergic neurotransmission may be warranted.
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